Kaya Ltd

AI
Kaya Ltd Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents
AI

Kaya Ltd

₹ 327 -3.30%
23 Sep - close price
kaya.in BSE: 539276 NSE: KAYA
About

Incorporated in 2003, Kaya Ltd provides
Skin and Hair care products & services[1]

Key Points

Business Overview:[1]
KL started as a division of Marico Limited
and later emerged as a separate entity. Currently, the promoter group owns a 59.93% stake in Kaya. The company is engaged in providing skincare and hair care solutions through a range of clinics across India and the Middle East.

Website BSE NSE - BE
  • Market Cap ₹ 506 Cr.
  • Current Price ₹ 327
  • High / Low ₹ 484 / 224
  • Stock P/E
  • Book Value ₹ -101
  • Dividend Yield 0.00 %
  • ROCE -45.6 %
  • ROE %
  • Face Value ₹ 10.0
Edit ratios

Pros

Cons

  • Company has low interest coverage ratio.
  • Promoter holding has decreased over last 3 years: -8.50%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Consumer Discretionary Consumer Services Leisure Services Wellness

Part of BSE Consumer Discretionary

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
50 52 56 53 52 52 58 55 53 54 60 56 60
40 75 44 134 40 47 57 49 49 57 71 68 56
Operating Profit 9 -23 12 -81 12 6 1 6 4 -3 -11 -13 4
OPM % 19% -44% 21% -152% 24% 11% 1.6% 11% 7% -6% -19% -23% 6%
1 1 1 2 11 1 1 4 1 4 -4 6 1
Interest 6 6 7 7 7 8 8 8 8 9 9 9 9
Depreciation 9 9 9 9 9 9 10 9 10 11 12 12 11
Profit before tax -5 -37 -3 -95 6 -11 -15 -7 -14 -19 -36 -28 -15
Tax % 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%
-5 -37 -3 -95 6 -11 -15 -7 -14 -19 -36 -28 -15
EPS in Rs -3.48 -27.95 -2.20 -72.54 4.97 -8.12 -11.76 -5.32 -10.74 -12.35 -23.41 -18.28 -9.99
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
174 185 194 201 210 204 117 141 178 210 217 222 230
166 194 211 209 206 167 99 127 205 291 189 244 253
Operating Profit 8 -9 -17 -8 4 37 18 14 -26 -81 28 -22 -24
OPM % 4.4% -4.8% -9% -4.0% 1.7% 18% 15% 10% -15% -38% 13% -10% -10%
16 12 11 10 5 9 13 9 4 5 15 7 8
Interest 2 2 2 2 3 14 12 14 33 27 32 38 36
Depreciation 6 10 11 13 15 44 32 35 30 35 38 44 45
Profit before tax 15 -9 -18 -14 -10 -13 -14 -25 -85 -139 -27 -96 -97
Tax % -0% 0% -14% -3% -58% 164% 0% 0% 0% 0% 0% 0%
15 -9 -16 -13 -4 -34 -14 -25 -85 -139 -27 -96 -97
EPS in Rs -6.68 -12.05 -10.24 -3.03 -25.98 -10.81 -19.50 -65.44 -106.18 -20.24 -63.30 -64.03
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: 2%
5 Years: 14%
3 Years: 8%
TTM: 5%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: -4%
TTM: -104%
Stock Price CAGR
10 Years: -9%
5 Years: -6%
3 Years: -2%
1 Year: -32%
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: %

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 0.00 13 13 13 13 13 13 13 13 13 13 15
Reserves 187 179 187 175 150 102 89 77 3 -130 -153 -168
0 0 1 0 0 103 103 154 168 220 256 296
97 87 84 73 97 86 72 79 119 118 120 135
Total Liabilities 284 278 284 261 260 303 277 323 303 221 237 278
32 46 48 50 43 113 92 80 95 132 158 193
CWIP 3 2 1 0 1 0 1 1 1 1 1 0
Investments 195 132 115 115 109 118 126 187 142 31 4 39
53 99 120 97 107 72 59 55 65 56 73 46
Total Assets 284 278 284 261 260 303 277 323 303 221 237 278

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
6 -22 -19 11 -2 32 18 34 47 40 15 21
-4 20 14 -8 -0 -12 -7 -74 -1 -35 14 -62
-0 0 4 -1 2 -24 -10 40 -32 -13 -30 37
Net Cash Flow 2 -2 0 2 1 -3 1 -0 14 -7 -2 -5
Free Cash Flow -18 -45 -31 -5 -10 28 17 25 33 10 3 -17
CFO/OP 87% 242% 111% -136% -95% 77% 101% 242% -180% -50% 52% -95%

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 1 4 4 7 10 11 14 13 10 8 4 1
Inventory Days 1,164 976 1,098 584 533 614 644
Days Payable 555 445 462 356 464 335 409
Cash Conversion Cycle 1 613 4 7 10 542 650 13 238 78 283 235
Working Capital Days -101 -1 -48 -42 -63 -92 -151 -165 -200 -173 -147 -230
ROCE % 2% -3% -11% -8% -5% 0% -1% -5% -25% -79% -6% -46%

Insights

In beta
Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Number of Clinics in India
count

Log in to view insights

Please log in to see hidden values.

Login
NPS Score (India)
score
Customer Count (India)
count
Innovation as % of Clinic Collections
% of collections
Kaya Smiles Collection Share
% of clinic collections
New Dermatology Machines Added
count
Services vs Products Revenue Mix (India)
% services

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

2 Recently
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
59.93% 59.93% 59.79% 59.79% 59.64% 59.64% 59.64% 59.64% 51.43% 51.43% 51.43% 51.43%
0.81% 0.73% 0.74% 1.25% 1.27% 1.27% 1.49% 0.95% 0.63% 0.63% 0.68% 0.71%
1.34% 1.34% 1.97% 3.53% 3.61% 3.37% 1.71% 2.09% 2.53% 2.79% 2.95% 2.99%
37.91% 38.01% 37.49% 35.44% 35.48% 35.72% 37.17% 37.32% 45.40% 45.15% 44.93% 44.88%
No. of Shareholders 22,38421,77420,89021,47720,02819,80419,83719,57418,72418,29517,93218,043

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls